Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactive astrocytes generated from human iPSC are pro-inflammatory and display altered metabolism.

Experimental neurology·2024
Same author

Dexamethasone attenuates inflammatory-mediated suppression of β<sub>2</sub>-adrenoceptor expression in rat primary mixed glia.

Journal of neuroimmunology·2019
Same author

Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.

International immunopharmacology·2019
Same author

Nanoparticle-induced neuronal toxicity across placental barriers is mediated by autophagy and dependent on astrocytes.

Nature nanotechnology·2018
Same author

Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's disease.

Brain, behavior, and immunity·2018
Same author

Induction of protein citrullination and auto-antibodies production in murine exposed to nickel nanomaterials.

Scientific reports·2018

Related Experiment Video

Updated: Jun 10, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Noreen T Boyle1, Thomas J Connor

  • 1Neuroimmunology Research Group, Department of Physiology, School of Medicine, Trinity College Institute of Neuroscience, Trinity College, Dublin, Ireland.

British Journal of Pharmacology
|August 20, 2010
PubMed
Summary

Methylenedioxymethamphetamine (MDMA) negatively impacts the immune system, suppressing both innate and adaptive immunity. This immunosuppression, linked to significant health risks, is primarily mediated by endogenous substances rather than direct drug action on immune cells.

More Related Videos

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Area of Science:

  • Immunology
  • Pharmacology
  • Neuroscience

Background:

  • Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy, is a widely abused amphetamine.
  • MDMA abuse presents numerous acute and chronic health risks, including significant adverse effects on immune system function.

Purpose of the Study:

  • To investigate the immunosuppressive properties of MDMA.
  • To elucidate the impact of MDMA on both innate and adaptive immune responses.
  • To explore the mechanisms underlying MDMA-induced immunosuppression and its health implications.

Main Methods:

  • Review of existing research on MDMA's effects on immune cells and cytokines.
  • Analysis of studies examining neutrophil function, cytokine production (TNF-α, IL-1β, IL-12, IL-15, IFN-γ), and antigen-presenting cell markers (MHC class II, co-stimulatory molecules).
  • Investigation into the role of endogenous immunomodulatory substances, beta-adrenoceptors, and cholinergic receptors in mediating MDMA's effects.

Main Results:

  • MDMA suppresses innate immunity by impairing neutrophil phagocytosis and reducing pro-inflammatory cytokine and IFN-γ production.
  • MDMA compromises adaptive immunity by decreasing lymphocyte counts (especially CD4+ T-cells), inhibiting T-cell proliferation, and promoting a Th2-skewed cytokine profile.
  • MDMA activates microglia in the central nervous system, paradoxically inducing pro-inflammatory effects.
  • Immunosuppression is largely mediated by endogenous substances acting via peripheral receptors, not direct drug action on immune cells.

Conclusions:

  • MDMA exerts broad immunosuppressive effects on both innate and adaptive immunity.
  • The mechanisms involve impaired immune cell function and altered cytokine profiles, with central nervous system effects also noted.
  • MDMA-induced immunosuppression poses significant health risks to drug abusers, mediated by endogenous pathways.